zacks.com / .zacks-com / Page 5

DVN builds scale and resilience through high-return acquisitions in different basins across the United States.

Pre-market futures are bouncing around a bit without much guidance from economic reports or Q2 earnings.

HOOD's new tokenized stock products draw scrutiny from Lithuania's central bank, raising EU compliance questions.

WMT boosts profits with surging ad sales, membership gains and marketplace growth to outpace retail rivals.

SoFi Technologies rides a 217% profit surge and $2B Fortress deal to scale its ecosystem and cut reliance on lending-heavy income.

NET's sharper sales execution and disciplined spending boost margins - but can the efficiency gains endure?

Cogent Biosciences stock jumps 23.4% after bezuclastinib hits primary and all key secondary endpoints in a phase III systemic mastocytosis study.

MU's Q3 gross margin hit 39% on strong DRAM and NAND pricing. Management sees Q4 margins hitting 42%.

MOH slashes 2025 EPS outlook by more than 10%, citing rising medical costs and echoing warnings from CNC and UnitedHealth.

F's escalating recall problems in 2025 are raising alarms about quality control, rising costs and investor confidence.